Skip to content

Clinical observation of target-controlled infusion of etomidate and propofol for anesthesia maintenance in elderly patients undergoing urological surgery

Clinical observation of target-controlled infusion of etomidate and propofol for anesthesia maintenance in elderly patients undergoing urological surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066623
Enrollment
Unknown
Registered
2022-12-12
Start date
2022-12-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia for elderly patients

Interventions

Etomidate group:etomidate TCI
Propofol group:Propofol TCI
Etomidate combined with propofol group:Etomidate combined with propofol TCI

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: a. patients scheduled for urological surgery; b. Aged 65 to 85 years old,gender unlimited; c. Body mass index (BMI) 18.5-30 kg/m2; d. American Society of Anesthesiologists (ASA) grade ?~?; e. New York Heart Association (NYHA) functional class ?~?; f. Duration of surgery less than 4 hours.

Exclusion criteria

Exclusion criteria: a. Patients with severe cerebral, pulmonary, hepatic, renal and metabolic diseases; b. Patients with acute inflammation of the respiratory tract within 2 weeks without cure and asthma; c. Preoperative patient SBP more than 180mmHg or DBP more than 110mmHg, or patients with hypotension less than 90/60 mmHg. d. Patients with anemia and abnormal coagulation function; e. Patients with neuromuscular diseases or mental disorders; f. Patients are suspected abuse of narcotic analgesics or sedatives; g. Patients who are allergic to the test drugs, with allergic diseases, or are allergic constitution; h. patients with adrenal diseases and immune diseases; i. patients had taken glucocorticoids or other immunosuppressive drugs within 6 months; j. Patients who declined to participate in this trial; k. Patients are uncooperative or inability to communicate.

Design outcomes

Primary

MeasureTime frame
dosage of anesthesia maintenance drugs;Blood pressure and heart rate;Oxygen saturation;Hemodynamic change;

Secondary

MeasureTime frame
Use of vasoactive drugs;

Countries

China

Contacts

Public ContactShen Qiying

The First Affiliated Hospital of Anhui Medical University

shenqiying-yy@163.com13956029032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026